Neostigmine and glycopyrrolate

DRUG4 trials

Sponsors

Tampere University Hospital, James J. Peters Veterans Affairs Medical Center, Ciusss de L'Est de l'Île de Montréal

Conditions

AnaesthesiaConstipationNeurogenic BowelNeuromuscular BlockadeSpinal Cord InjuriesSpinal Cord Injury

Early Phase 1

Transdermal Administration of a Prokinetic Agent for Bowel Evacuation in Persons With SCI

CompletedNCT02370862

James J. Peters Veterans Affairs Medical CenterNeurogenic Bowel, Spinal Cord Injury

Start: 2013-02-28End: 2016-12-31Updated: 2017-03-07

Phase 1

Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI

CompletedNCT04671030

James J. Peters Veterans Affairs Medical CenterConstipation, Neurogenic Bowel, Spinal Cord Injuries

Start: 2018-01-15End: 2021-06-03Updated: 2021-12-30

Phase 4

Sugammadex and Brain Waves

CompletedNCT01142648

Tampere University HospitalAnaesthesia

Start: 2009-04-30End: 2010-03-31Target: 30Updated: 2010-06-11

Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium

CompletedNCT05718934

Ciusss de L'Est de l'Île de MontréalNeuromuscular Blockade

Start: 2022-11-08End: 2023-12-19Updated: 2024-02-20

Related Papers

Low dose of sugammadex versus neostigmine for reversal of rocuronium induced moderate neuromuscular block: a randomized controlled trial.

2026-01-17